NUVL
NUVL
NASDAQ · Biotechnology

Nuvalent Inc-A

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$105.28
+2.88 (+2.81%)
As of May 9, 1:13 AM ET ·
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Buy 24 96%
Hold 1 4%
Sell 0 0%
Price Target
Analyst Price Target -68.4% upside
Low Target $20.12
Average Target $33.28
High Target $44.46
Current Price $105.28
Current
$105.28
Target
$33.28
$20.12 $33.28 avg $44.46
Scenario Analysis
Bear Case
$20.12
-80.9%
Low target
Base Case
$33.28
-68.4%
Avg target
Bull Case
$44.46
+-57.8%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$113.02
-6.8% from high
52-Week Low
$63.56
+65.7% from low
50-Day SMA
$103.76
+1.5% vs SMA
200-Day SMA
$88.57
+18.9% vs SMA
RSI (14)
53.7
Neutral
Target vs 52W High
$33.28
-70.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%